| Literature DB >> 35890178 |
Seyyed Mojtaba Mousavi1, Seyyed Alireza Hashemi2, Masoomeh Yari Kalashgrani3, Navid Omidifar4, Chin Wei Lai5, Neralla Vijayakameswara Rao1, Ahmad Gholami3, Wei-Hung Chiang1.
Abstract
The spread of viral diseases has caused global concern in recent years. Detecting viral infections has become challenging in medical research due to their high infectivity and mutation. A rapid and accurate detection method in biomedical and healthcare segments is essential for the effective treatment of pathogenic viruses and early detection of these viruses. Biosensors are used worldwide to detect viral infections associated with the molecular detection of biomarkers. Thus, detecting viruses based on quantum dots biomarkers is inexpensive and has great potential. To detect the ultrasensitive biomarkers of viral infections, QDs appear to be a promising option as biological probes, while physiological components have been used directly to detect multiple biomarkers simultaneously. The simultaneous measurement of numerous clinical parameters of the same sample volume is possible through multiplex detection of human viral infections, which reduces the time and cost required to record any data point. The purpose of this paper is to review recent studies on the effectiveness of the quantum dot as a detection tool for human pandemic viruses. In this review study, different types of quantum dots and their valuable properties in the structure of biomarkers were investigated. Finally, a vision for recent advances in quantum dot-based biomarkers was presented, whereby they can be integrated into super-sensitive probes for the multiplex detection of human viral infections.Entities:
Keywords: biomarkers; multiplex detection; quantum dots; ultra-sensitive probes; viral infections
Year: 2022 PMID: 35890178 PMCID: PMC9319763 DOI: 10.3390/ph15070880
Source DB: PubMed Journal: Pharmaceuticals (Basel) ISSN: 1424-8247
Overview of electrochemical and optical nanobiosensors in viral detection.
| Detection Method | Nanomaterial | Limit of Detection | Type of Virus | Ref. | |
|---|---|---|---|---|---|
| Electrochemical nanobiosensors | SWCNTs | Nanotubes | 102 CFU/mL | Bacillus subtilis | [ |
| Change in output voltage | - | 6.9 copies/µL of viral RNA |
| [ | |
| Amperometric readings | - | - |
| [ | |
| FET sensor, transfer curve shift | - | 2.29 fM–3.99 fM | SARS-CoV-2 RNA | [ | |
| Amperometry | Silver graphene QDs (Ag/GQDs) | 1ZM | Legionella | [ | |
| glip-T | 1,6-Hexanedithiol and chitosan stabilized gold nanoparticle | 0.32 ± 0.01 × 10-[ | Invasive Aspergillosis (IA) | [ | |
| Optical nanobiosensors | Fluorescence | CdTe QDs | 0.13 µg mL−1 | Citrus tristeza virus (CTV) | [ |
| LSPR, plasmonic photothermal heating (dual sensor) | - | 0.22 ± 0.08 pM (2.26 × 104 copies of viral RNA) | Coronavirus 2 | [ | |
| Fluorescence | - | 12.6 nM of spike RBD | COVID-19 | [ | |
| Terahertz plasmonic sensor | - | 4.2 fM |
| [ | |
| SPRi | AuNPs induced with QDs | 0.03 pg/mL and 0.4 pg/mL, 10 PFU/mL | Influenza | [ | |
| Fluorescence | Nanobeads | 102–103 CFU/mL |
| [ |
Figure 1QD-based nanosensors to detect viruses.
Advantages and disadvantages of semiconductor, carbon, and graphene quantum dots.
| Advantages | Disadvantages | Ref. | |
|---|---|---|---|
| Semiconductor quantum dots |
High photostability Resistance to photobleaching The narrow and symmetric peak of emission Stokes shift is more than 200 nm (ease to detection) High quantum yield Long lifetime Resistance to chemical and biological degradation |
The multiexponential decline of fluorescence and blinking of separate QDs The high background level of deduction and accumulation of QDs in the reticuloendothelial system Incomplete elimination of QDs after injection into an organism The high toxicity of QDs when used in in vivo systems | [ |
| Carbon quantum dots |
Non-toxic Cost-effective Eco-friendly Simple Cheap Facile Rapid Scalable Size and nanostructure are controllable |
Toxic acid/base reagents Broad size distribution Expensive oxidants Long synthesis duration | [ |
| Graphene quantum dots |
Simple and effective Environmentally friendly Shorten the reaction time Improve the production yield High levels of stability Uniform size distribution |
Some strong oxidizers cause burning or explosion The carbon materials need to be treated through strong oxidation before the reactions happen Difficult to realize mass production because of the low product yield | [ |
Figure 2Classification of nanobiosensors for viral detection.
Figure 3Fluorescence-based on QDs for detecting pandemic viruses.
Figure 4QD-coated viral nanowire for detecting pandemic viruses.
Figure 5The GQD for detecting HIV.
Figure 6QD carbon nanotubes detect pandemic viruses.
Figure 7QD-based biomarker features for the detection of viral disease.
QD-based biomarkers that are made to detect biomarkers of infectious diseases.
| Infectious Disease | Infectious Biomarker | Detection Techniques | Ref. |
|---|---|---|---|
| Hepatitis B | HBV virus | Microfluidic device with microbead array and QD | [ |
| HIV | Anti-HIV antibody | Biosensors | [ |
| Hepatitis C | Anti-HCV antibodies | Optical immunosensors | [ |
| Autoimmune hepatitis | Serum levels: IL-6, IL-8, IL-17, IL-21, tumor necrosis factor (TNF)-α | enzyme-linked immunosorbent assay | [ |
| Hepatitis B | Hepatitis B surface antibodies | Surface acoustic wave immunosensor | [ |
Figure 8Detection of coronaviruses by using QD-based graphene biomarker.
Figure 9Detection of HIV by using QD-based biomarkers made from CdSe with optical sensors.
Figure 10Detection of HPV infection by using dual-color QD detection method.
Figure 11Detection of hepatitis C and hepatitis B virus using CdTe multicolor QDs and gold nanoparticles in the electro-quantitative luminescence method.
QD-based biomarkers in multiplex detection of viral infections.
| Biomarkers | Detection Time | Analysis Mode | Detection Method | Ref. |
|---|---|---|---|---|
| CEA and NSE | <15 min | Quantitative | Fluorescent detection | [ |
| Myo, cTnI, and CKMB | 17 min | Quantitative | SERS detection | [ |
| PSA and EphA2 | Not mentioned | Quantitative | Fluorescent detection | [ |
| BoNT-A, BoNT-B, and BoNT-E | 25 min | Quantitative | Magnetic detection | [ |
| SD, TC, and CT | 10 min | Semiquantitative | Colorimetric detection | [ |
| DENV NS1 and ZIKV NS1 | Not mentioned | Quantitative | SERS detection | [ |
| AFP and CEA | 30 min | Semiquantitative | Colorimetric detection | [ |
| Myo, cTnI, and CKMB | 45 min | Quantitative | SERS detection | [ |
| MOP, fentanyl, and MET | <20 min | Quantitative | Magnetic detection | [ |